Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0HI0L
|
|||
| Former ID |
DIB011487
|
|||
| Drug Name |
HSV-1716
|
|||
| Synonyms |
Seprehvir; HSV-based oncolytic virus therapy (cancer), Crusade; ICP34.5-null herpes simplex virus-1; Cancer therapy (HSV-1), University of Pennsylvania/Wistar Institute
Click to Show/Hide
|
|||
| Indication | Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C76-C80; ICD-9: 140-229] | Phase 1/2 | [1] | |
| Company |
Crusade Laboratories Ltd
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01721018) Intrapleural Administration of HSV1716 to Treat Patients With Malignant Pleural Mesothelioma.. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.